Small interfering RNA (siRNA) phosphate backbone (siRNA phosphate backbone)

The small interfering RNA (siRNA) phosphate backbone is the structural framework of double-stranded RNA molecules involved in the RNA interference (RNAi) pathway. It consists of alternating phosphate groups and ribose sugars that link nucleotides via 3'-5' phosphodiester bonds. In therapeutic applications, the native phosphodiester backbone is often chemically modified—most commonly into a phosphorothioate linkage—to protect the molecule from rapid degradation by exonucleases and endonucleases in the bloodstream and cellular environment (Khvorova & Watts, 2017, Nature Biotechnology; Roberts et al., 2020, Nature Reviews Drug Discovery). This backbone is essential for the biological activity of siRNA, as its negative charge and specific geometry allow it to be recognized and bound by the Argonaute 2 (AGO2) protein within the RNA-induced silencing complex (RISC) (Schirle & MacRae, 2012, Science). Once loaded into RISC, the siRNA guides the complex to a complementary messenger RNA (mRNA) sequence, leading to its cleavage and the subsequent knockdown of the target protein (Setten et al., 2019, Nature Reviews Drug Discovery). While the backbone itself is not a traditional therapeutic target like a receptor or enzyme, it is a critical site for chemical optimization to improve the stability, cellular uptake, and pharmacokinetics of siRNA-based drugs (Hu et al., 2020, Signal Transduction and Targeted Therapy).

Other names

Phosphodiester backboneInternucleotide linkageRNA backbonePhosphorothioate backbone

The phosphate backbone provides the structural scaffold for siRNA, enabling its recognition and loading into the RNA-induced silencing complex (RISC) for sequence-specific mRNA degradation.